BESREMI sol inj 250 mcg/0.5 ml stylo pré 0.5 ml
7680674880011
CH-67488
L03AB15
07.16.1.
Reimbursement limitations:
BESREMI.01
BESREMI est remboursé en monothérapie, après accord de prise en charge par l'assureur-maladie et consultation …
1 / 3
google
Details
- Product number
- 6748801
- CPT
- -
- Packaging group
- 1
- Unit
- Injektor(en), vorgefüllt/Pen
- Composition
- ropeginterferonum alfa-2b 250 µg, natrii chloridum, natrii acetas, acidum aceticum glaciale, alcohol benzylicus 5 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.8 mg.
Articles (1)
Besremi 250 μg / 0,5 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.8 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1653.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2021
Authorization holder
OrPha Swiss GmbH
8700 Küsnacht ZH
Authorization information
- Swissmedic authorization number
- 67488
- Drug name
- Besremi, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- L03AB15
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 01/07/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BESREMI sol inj 250 mcg/0.5 ml stylo pré 0.5 ml
- Description (DE)
- BESREMI Inj Lös 250 mcg/0.5 ml Fertpen 0.5 ml
- Market launch
- 01/07/2020
- Narcotic (BTM)
- No